Return On Equity of ABVC BIOPHARMA, INC. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
ABVC BIOPHARMA, INC. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • ABVC BIOPHARMA, INC. Return On Equity for the quarter ending 30 Sep 2025 was -62%, a 81% increase year-over-year.
  • ABVC BIOPHARMA, INC. annual Return On Equity for 2024 was -388%, a 67% decline from 2023.
  • ABVC BIOPHARMA, INC. annual Return On Equity for 2023 was -232%, a 9.9% increase from 2022.
  • ABVC BIOPHARMA, INC. annual Return On Equity for 2022 was -258%, a 6.1% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

ABVC BIOPHARMA, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -62% +264% +81% 01 Jul 2025 30 Sep 2025
Q2 2025 -87% +138% +61% 01 Apr 2025 30 Jun 2025
Q1 2025 -101% +167% +62% 01 Jan 2025 31 Mar 2025
Q4 2024 -388% -155% -67% 01 Oct 2024 31 Dec 2024
Q3 2024 -326% -7.2% -2.3% 01 Jul 2024 30 Sep 2024
Q2 2024 -225% +196% +47% 01 Apr 2024 30 Jun 2024
Q1 2024 -268% -21% -8.5% 01 Jan 2024 31 Mar 2024
Q4 2023 -232% +26% +9.9% 01 Oct 2023 31 Dec 2023
Q3 2023 -319% -69% -28% 01 Jul 2023 30 Sep 2023
Q2 2023 -421% -209% -98% 01 Apr 2023 30 Jun 2023
Q1 2023 -247% +43% +15% 01 Jan 2023 31 Mar 2023
Q4 2022 -258% +17% +6.1% 01 Oct 2022 31 Dec 2022
Q3 2022 -250% +68% +22% 01 Jul 2022 30 Sep 2022
Q2 2022 -212% +893% +81% 01 Apr 2022 30 Jun 2022
Q1 2022 -290% +2099% +88% 01 Jan 2022 31 Mar 2022
Q4 2021 -275% -3972% -107% 01 Oct 2021 31 Dec 2021
Q3 2021 -318% -1004% -146% 01 Jul 2021 30 Sep 2021
Q2 2021 -1106% -2287% -194% 01 Apr 2021 30 Jun 2021
Q1 2021 -2389% -2860% -607% 01 Jan 2021 31 Mar 2021
Q4 2020 3697% +3502% +1795% 01 Oct 2020 31 Dec 2020
Q3 2020 686% +482% +237% 01 Jul 2020 30 Sep 2020
Q2 2020 1181% +1023% +646% 01 Apr 2020 30 Jun 2020
Q1 2020 471% +280% +146% 01 Jan 2020 31 Mar 2020
Q4 2019 195% -136% -41% 01 Oct 2019 31 Dec 2019
Q3 2019 203% -579% -74% 01 Jul 2019 30 Sep 2019
Q2 2019 158% 01 Apr 2019 30 Jun 2019
Q1 2019 192% 01 Jan 2019 31 Mar 2019
Q4 2018 331% 01 Oct 2018 31 Dec 2018
Q3 2018 782% 01 Jul 2018 30 Sep 2018

ABVC BIOPHARMA, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -388% -155% -67% 01 Jan 2024 31 Dec 2024
2023 -232% +26% +9.9% 01 Jan 2023 31 Dec 2023
2022 -258% +17% +6.1% 01 Jan 2022 31 Dec 2022
2021 -275% -3972% -107% 01 Jan 2021 31 Dec 2021
2020 3697% +3502% +1795% 01 Jan 2020 31 Dec 2020
2019 195% -136% -41% 01 Jan 2019 31 Dec 2019
2018 331% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.